Basic Information
| ID | DRAMP03852 |
|---|
| Sequence | GLARIVVIRVAR |
|---|
| Length | 12 |
|---|
| Name | G1 (Bac2A variant through single amino acid substitution) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal |
|---|
| Pathogen | Gram-negative bacteria: Pseudomonas aeruginosa (MIC=125 µg/ml), Escherichia coli (MIC=16 µg/ml), Salmonella typhimurium (MIC=63 µg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 µg/ml), Staphylococcus epidermidis (MIC=16 µg/ml), Enterococcus faecalis (MIC=31 µg/ml).##Yeast: Candida albicans (MIC=125 µg/ml). |
|---|
| Hemolytic Activity | No hemolysis information or data found in the reference(s) presented in this entry |
|---|
| Cytotoxicity | Not included yet |
|---|
| N-terminal Modification | Not included yet |
|---|
| C-terminal Modification | Not included yet |
|---|
| Linear/Cyclic/Branched | Not included yet |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 16041366 |
|---|
